HK Biotech Firm Metis TechBio Pioneers AI Nano-Rockets
Hong Kong-listed biotech firm Metis TechBio is utilizing artificial intelligence to develop nano-rockets for the precise delivery of life-saving drugs. The company is also set for its debut following an initial public offering.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)Sources
AI Life Science Firm Metis TechBio Set for HK Debut After IPO - Bloomberg.com
AI Life Science Firm Metis TechBio Set for HK Debut After IPO Bloomberg.com
Read full article →Hong Kong-listed biotech firm uses AI to produce nano-rockets to deliver life-saving drugs
Shares of METiS TechBio surged on their Hong Kong debut Wednesday as the AI-driven drug design start-up’s initial public offering drew strong demand from investors amid buoyant sentiment for AI-related stocks in the city. Artificial intelligence has shortened drug development from years to just 18 months, said Lai Tsai-Ta, co-founder and CEO of METiS TechBio, who obtained a PhD from the Massachusetts Institute of Technology in the US. “We see ourselves like a SpaceX-style company,” he said. “...
By Julie Zhang
Read full article →
